Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting.
Hussain, M; Melegaro, A; Pebody, RG; George, R; EDMUNDS, WJ; Talukdar, R; Martin, SA; Efstratiou, A; MILLER, E;
2005
Epidemiology and infection, (2005).133 5 10.1017/S0950268805004012.
Non-specific effects of vaccination: Author's reply to Shann.
FINE, PE M;
2005
BMJ, (2005).330 7495 10.1136/bmj.330.7495.844-a.
Non-specific effects of vaccination.
FINE, PE M;
2005
BMJ (Clinical research ed), (2005).330 7495 10.1136/bmj.330.7495.844-a.
A global call for new polio vaccines.
HEYMANN, DL; Sutter, RW; Aylward, RB;
2005
Nature, (2005).434 7034 10.1038/434699a.
Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy.
D'Ancona, F; Salmaso, S; Barale, A; BOCCIA, D; Lopalco, PL; Rizzo, C; Monaco, M; Massari, M; Demicheli, V; Pantosti, A; Italian PNC-Euro working group,;
2005
Vaccine, (2005).23 19 10.1016/j.vaccine.2004.10.037.
Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy.
Ameratunga, S; Macmillan, A; Stewart, J; Scott, D; MULHOLLAND, K; Crengle, S; Meningococcal Management Team,;
2005
Vaccine, (2005).23 17-18 10.1016/j.vaccine.2005.01.048.
From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease.
O'Hallahan, J; Lennon, D; Oster, P; Lane, R; Reid, S; MULHOLLAND, K; Stewart, J; Penney, L; Percival, T; Martin, D;
2005
Vaccine, (2005).23 17-18 10.1016/j.vaccine.2005.01.061.
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.
Oster, P; Lennon, D; O'Hallahan, J; MULHOLLAND, K; Reid, S; Martin, D;
2005
Vaccine, (2005).23 17-18 10.1016/j.vaccine.2005.01.063.
An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
MANGTANI, P; Roberts, JA; Hall, AJ; Cutts, FT;
2005
International journal of epidemiology, (2005).34 3 10.1093/ije/dyh341.
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
Cutts, FT; ZAMAN, SM A; Enwere, G; Jaffar, S; Levine, OS; Okoko, JB; Oluwalana, C; Vaughan, A; Obaro, SK; Leach, A; MCADAM, KP; Biney, E; Saaka, M; Onwuchekwa, U; Yallop, F; Pierce, NF; GREENWOOD, BM; Adegbola, RA; Gambian Pneumococcal Vaccine Trial Group,;
2005
Lancet, (2005).365 9465 10.1016/S0140-6736(05)71876-6.